- Home
- KVAC vs PBYI Comparison
KVAC vs PBYI Comparison
Compare KVAC & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVAC
- PBYI
- Stock Information
- Founded
- KVAC 2021
- PBYI 2010
- Country
- KVAC United States
- PBYI United States
- Employees
- KVAC N/A
- PBYI N/A
- Industry
- KVAC
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- KVAC
- PBYI Health Care
- Exchange
- KVAC Nasdaq
- PBYI Nasdaq
- Market Cap
- KVAC 120.9M
- PBYI 138.4M
- IPO Year
- KVAC 2023
- PBYI N/A
- Fundamental
- Price
- KVAC N/A
- PBYI $2.86
- Analyst Decision
- KVAC
- PBYI Strong Buy
- Analyst Count
- KVAC 0
- PBYI 1
- Target Price
- KVAC N/A
- PBYI $7.00
- AVG Volume (30 Days)
- KVAC 689.0
- PBYI 334.3K
- Earning Date
- KVAC 01-01-0001
- PBYI 05-01-2025
- Dividend Yield
- KVAC N/A
- PBYI N/A
- EPS Growth
- KVAC 197.31
- PBYI 37.78
- EPS
- KVAC 0.41
- PBYI 0.62
- Revenue
- KVAC N/A
- PBYI $230,468,000.00
- Revenue This Year
- KVAC N/A
- PBYI N/A
- Revenue Next Year
- KVAC N/A
- PBYI N/A
- P/E Ratio
- KVAC $27.21
- PBYI $4.61
- Revenue Growth
- KVAC N/A
- PBYI N/A
- 52 Week Low
- KVAC $10.47
- PBYI $2.23
- 52 Week High
- KVAC $11.25
- PBYI $5.34
- Technical
- Relative Strength Index (RSI)
- KVAC 72.19
- PBYI 42.27
- Support Level
- KVAC $11.20
- PBYI $2.83
- Resistance Level
- KVAC $11.14
- PBYI $2.99
- Average True Range (ATR)
- KVAC 0.00
- PBYI 0.17
- MACD
- KVAC 0.00
- PBYI -0.01
- Stochastic Oscillator
- KVAC 100.00
- PBYI 50.00
About KVAC Keen Vision Acquisition Corporation
Keen Vision Acquisition Corp is a blank check company.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.